14,431 results on '"Huang AS"'
Search Results
2. Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
3. Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
4. An LGR6 frameshift variant abrogates receptor expression on select leukocyte subsets and is associated with viral infections
5. let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching
6. Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/Hoxa9/Prmt1 axis
7. Genetic basis of pregnancy-associated decreased platelet counts and gestational thrombocytopenia
8. Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia
9. Follicular lymphoma comprises germinal center–like and memory-like molecular subtypes with prognostic significance
10. Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs
11. Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma
12. Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade
13. All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP
14. Safety and efficacy of an anti–human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models
15. The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment
16. The palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML
17. Genomic landscape of Down syndrome–associated acute lymphoblastic leukemia
18. Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice.
19. Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
20. Molecular basis of polycomb group protein–mediated fetal hemoglobin repression
21. In vivo HSC prime editing rescues sickle cell disease in a mouse model
22. Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial
23. Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation
24. Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
25. Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
26. PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371
27. Epo-IGF1R cross talk expands stress-specific progenitors in regenerative erythropoiesis and myeloproliferative neoplasm
28. Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy
29. Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion
30. Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma
31. Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL/LBL: first-in-human phase 1 clinical trial
32. Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL
33. Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
34. Macrophage NOX2 NADPH oxidase maintains alveolar homeostasis in mice
35. Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression
36. Intestinal IL-33 promotes platelet activity for neutrophil recruitment during acute inflammation
37. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma
38. Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL
39. ORP4L is a prerequisite for the induction of T-cell leukemogenesis associated with human T-cell leukemia virus 1
40. RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway
41. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy
42. Single-cell landscape of idiopathic multicentric Castleman disease in identical twins
43. Identification and transcriptome analysis of erythroblastic island macrophages
44. Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice
45. Activity of transgene-produced B-domain–deleted factor VIII in human plasma following AAV5 gene therapy
46. Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice
47. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF
48. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression
49. Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
50. Shared roles for Scl and Lyl1 in murine platelet production and function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.